On August 13, 2026, Edesa Biotech, Inc. (Nasdaq: EDSA), a company specializing in host-directed therapeutics for immuno-inflammatory diseases, released its financial data for the three and nine months concluding on June 30, 2026. The report also featured an overview of the company's recent business activities.